Clinical Trial Update: Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan [Phase 2]

View source ↗

Summary

Phase 2 trial update of the safety and immunogenicity of a tetravalent dengue vaccine admixture TV005 in elderly adults (50-70) in Taiwan; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• TV005

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Dengue | Phase 2 | Status: COMPLETED